CANbridge Pharmaceuticals Inc. (01228)
| Auditor | From | To | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|
| HLB Hodgson Impey Cheng | 05-Dec-24 | |||
| Ernst & Young (Hong Kong) | 05-Dec-24 | Lack of agreement on the proposed audit fee in respect of the audit of the Group’s consolidated financial statements for the year ending December 31, 2024. |